You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API atropine sulfate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing atropine sulfate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 BENZALKONIUM CHLORIDE
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 BORIC ACID
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 HYDROCHLORIC ACID
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 HYPROMELLOSES
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 SODIUM HYDROXIDE
Alcon Laboratories Inc ISOPTO ATROPINE atropine sulfate 0065-0303 WATER
Alcon Laboratories Inc ATROPINE SULFATE atropine sulfate 0065-0817 BENZALKONIUM CHLORIDE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Subscribe

Excipients in ANDA-approved (generic) drugs containing atropine sulfate

Company Ingredient NDC Excipient
Henry Schein Inc atropine sulfate 0404-9802 SODIUM CHLORIDE
Henry Schein Inc atropine sulfate 0404-9802 SODIUM HYDROXIDE
Henry Schein Inc atropine sulfate 0404-9802 SULFURIC ACID
Henry Schein Inc atropine sulfate 0404-9802 WATER
American Regent Inc atropine sulfate 0517-1004 SODIUM CHLORIDE
American Regent Inc atropine sulfate 0517-1004 SODIUM HYDROXIDE
American Regent Inc atropine sulfate 0517-1004 SULFURIC ACID
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Subscribe

Detailed excipient profiles for atropine sulfate

Excipient focus: BENZALKONIUM CHLORIDE

Excipient focus: BENZYL ALCOHOL

atropine sulfate drug variants containing BENZYL ALCOHOL

Company Ingredient NDC
Henry Schein Inc atropine sulfate 0404-9804
Hikma Pharmaceuticals USA Inc atropine sulfate 0641-6251
Accord Healthcare Inc atropine sulfate 16729-512
HF Acquisition Co LLC DBA HealthFirst atropine sulfate 51662-1619
Fresenius Kabi USA LLC atropine sulfate 63323-580
REMEDYREPACK INC atropine sulfate 70518-4188
Medical Purchasing Solutions LLC atropine sulfate 71872-7255
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: BORIC ACID

Excipient focus: EDETATE DISODIUM

Excipient focus: EDETATE SODIUM

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: SODIUM CHLORIDE

Excipient focus: SODIUM HYDROXIDE

atropine sulfate drug variants not containing SODIUM HYDROXIDE

Company Ingredient NDC
Henry Schein Inc atropine sulfate 0404-9804
Hikma Pharmaceuticals USA Inc atropine sulfate 0641-6251
Accord Healthcare Inc atropine sulfate 16729-512
HF Acquisition Co LLC DBA HealthFirst atropine sulfate 51662-1619
Fresenius Kabi USA LLC atropine sulfate 63323-580
REMEDYREPACK INC atropine sulfate 70518-4188
Medical Purchasing Solutions LLC atropine sulfate 71872-7255
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM PHOSPHATE, DIBASIC

atropine sulfate drug variants containing SODIUM PHOSPHATE, DIBASIC

Company Ingredient NDC
MWI atropine sulfate 13985-606
Akorn atropine sulfate 17478-215
A-S Medication Solutions atropine sulfate 50090-3104
A-S Medication Solutions atropine sulfate 50090-6295
A-S Medication Solutions atropine sulfate 50090-7000
A-S Medication Solutions atropine sulfate 50090-7313
Amneal Pharmaceuticals NY LLC atropine sulfate 60219-1748
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

atropine sulfate drug variants not containing SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE

Company Ingredient NDC
Alcon Laboratories Inc atropine sulfate 0065-0303
Alcon Laboratories Inc atropine sulfate 0065-0817
Henry Schein Inc atropine sulfate 0404-9802
Henry Schein Inc atropine sulfate 0404-9804
Henry Schein Inc atropine sulfate 0404-9988
Henry Schein Inc atropine sulfate 0404-9989
Hospira Inc atropine sulfate 0409-1630
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

atropine sulfate drug variants containing SODIUM PHOSPHATE, MONOBASIC

Company Ingredient NDC
MWI atropine sulfate 13985-606
Akorn atropine sulfate 17478-215
A-S Medication Solutions atropine sulfate 50090-3104
A-S Medication Solutions atropine sulfate 50090-6295
A-S Medication Solutions atropine sulfate 50090-7000
A-S Medication Solutions atropine sulfate 50090-7313
Amneal Pharmaceuticals NY LLC atropine sulfate 60219-1748
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

atropine sulfate drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Company Ingredient NDC
Alcon Laboratories Inc atropine sulfate 0065-0303
Alcon Laboratories Inc atropine sulfate 0065-0817
Henry Schein Inc atropine sulfate 0404-9802
Henry Schein Inc atropine sulfate 0404-9804
Henry Schein Inc atropine sulfate 0404-9988
Henry Schein Inc atropine sulfate 0404-9989
Hospira Inc atropine sulfate 0409-1630
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Excipient focus: SULFURIC ACID

Excipient focus: WATER

atropine sulfate drug variants not containing WATER

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc atropine sulfate 0641-6251
A-S Medication Solutions atropine sulfate 50090-5924
HF Acquisition Co LLC DBA HealthFirst atropine sulfate 51662-1527
HF Acquisition Co LLC DBA HealthFirst atropine sulfate 51662-1619
Somerset Therapeutics LLC atropine sulfate 70069-581
REMEDYREPACK INC atropine sulfate 70518-3120
Lifestar Pharma LLC atropine sulfate 70756-651
>Company >Ingredient >NDC

Subscribe to access the full database, or Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group